Innate Immune Cells in Non-Small Cell Lung Cancer: Roles in Tumor Progression and Therapeutic Responses
Jiaxin Liu1,2, Jie Jia1,2, Chong Wang3
1School of Engineering Medicine Beihang University Beijing China.
Cancer Innovation
|August 4, 2026
Summary
Innate immune cells (IICs) play a crucial role in non-small cell lung cancer (NSCLC) development and treatment. Understanding IIC functions and targeting them offers new avenues for effective NSCLC immunotherapy.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Non-small cell lung cancer (NSCLC) is a major global health concern, with innate immune cells (IICs) significantly impacting its progression and treatment outcomes.
- IICs are vital for immune defense and orchestrating adaptive immunity, but also play complex roles in NSCLC initiation, growth, and response to therapy.
Purpose of the Study:
- To review the classification, plasticity, and functions of IICs within the NSCLC tumor microenvironment.
- To summarize current therapeutic strategies targeting IICs in NSCLC.
- To discuss challenges and future directions for NSCLC immunotherapy focused on IICs.
Main Methods:
- Comprehensive literature review of studies on IICs in NSCLC.
- Analysis of IIC roles in NSCLC initiation, progression, and therapeutic response.
- Synthesis of information on IIC-targeting therapies and future perspectives.
Main Results:
- IICs exhibit diverse phenotypes and functions, profoundly influencing NSCLC.
- IIC-TME interactions are critical for NSCLC pathogenesis.
- Targeting IICs presents a promising strategy for enhancing NSCLC immunotherapy.
Conclusions:
- A deeper understanding of IIC biology in NSCLC is essential for advancing immunotherapy.
- Modulating IICs holds significant potential for improving NSCLC treatment efficacy.
- Future research should focus on novel IIC-centered therapeutic approaches for NSCLC.
Related Concept Videos
01:28Cells of the Innate Immune Response
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
02:39lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...